University of California San Francisco
Give to UCSF<p>President Barack Obama announced his intent to nominate UCSF's Mack Roach, who is recognized as a major authority on the treatment of prostate cancer, to the National Cancer Advisory Board.</p>
William Seeley maps the path of frontotemporal dementia through the brain, correlating specific damage with behavioral change. By studying the disease from self to circuits to cells, this visionary neurologist searches for inroads to treatment.
UCSF scientists have uncovered the molecular basis of gentle touch, one of the most fundamental but least well understood of our senses.
<p>As asthma rates continue to rise in the U.S. — proportionally affecting more children than adults — experts at UCSF and across the nation continue to search for the best medicines for pediatric patients.</p>
Dave Robb began working at UCSF 13 years ago, in 1999, when he was hired as science coordinator for both the Center for AIDS Prevention Studies (CAPS) and the AIDS Research Institute (ARI), working half time for each.
<p>The holidays are typically a joyful time of year, but UCSF police remind us not to forget that crime can occur any time or day.</p>
<p>The UCSF School of Nursing has updated the curriculum for master of science students so that they can provide high-quality, patient-centered care.</p>
<p>Shinya Yamanaka, MD, PhD, and John Gurdon, PhD, are in Stockholm this week to receive the 2012 Nobel Prize in Physiology or Medicine for their discoveries that led to the development of induced pluripotent stem cells.</p>
Severe acute kidney injuries are becoming more common in the United States, rising 10 percent per year and doubling over the last decade, according to a retrospective study at the University of California, San Francisco (UCSF).
<p>Robert A. Fishman, MD, former chair of the Department of Neurology at UCSF, died on Dec. 4, 2012 from complications of Alzheimer’s disease. He was 88.</p>
Scientists at the Gladstone Institutes, which is affiliated with UCSF, are recommending a shift in efforts to treat Alzheimer’s disease by developing drugs that target the apoE4 protein, which has long been associated with an increased risk for the disease.
<p>The rate of cancer survival is expected to keep climbing in coming years largely thanks to research discoveries that are translating into new cancer drugs, which currently account for roughly 30 percent of the pharmaceutical dollar, the chief scientific officer at Bristol-Myers Squib recently said at a showcase event for the UCSF Helen Diller Family Comprehensive Cancer Center.</p>